Celularity flags Fontaine Vitale strategic collaboration ahead of Q1 2027 opening in Bali

By Public Technologies
  • Celularity flagged Fontaine Vitale, a regenerative medicine and wellness center in Bali’s Sanur SEZ, as a strategic partner ahead of a Q1 2027 opening.
  • Facility is being developed by Genting Berhad with Indonesian partners, with Celularity providing strategic collaboration and input.
  • Celularity expects to supply placenta-derived cellular therapy products made in New Jersey, subject to final commercial terms and regulatory authorizations.
  • Company positions the partnership as a new Asia-Pacific market entry, targeting incremental revenue as patient volumes ramp post-opening.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609301157PRIMZONEFULLFEED9837102) on September 30, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk